youtube_live
Q4 2026 earnings • in 1 day
See detailschevron_right
COR:NYSE
Cencora Inc
$337.84
arrow_upward
+2.11%(+6.97) 1D
$337.20
arrow_downward
-0.19% (-0.64)todayPre-market
Closed: Nov 2, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
$333.26
High
$338.19
Low
$329.15
Mkt. cap
14.93B
Avg. vol.
1.19M
Volume
475.00
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
Open
$333.26
High
$338.19
Low
$329.15
Mkt. cap
14.93B
Avg. vol.
1.19M
Volume
475.00
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
News stories
From web sources and news partners
FinancialContent
·
8 hours ago
Cencora (COR) to report earnings tomorrow: here is what to expect
Yahoo Finance
·
2 days ago
Cencora (COR) Stock Still Looks Undervalued After Its 173% Run
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc